Detalhe da pesquisa
1.
Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation.
Circulation
; 139(5): 604-616, 2019 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30586700
2.
Clopidogrel Monotherapy vs. Aspirin Monotherapy Following Short-Term Dual Antiplatelet Therapy in Patients Receiving Everolimus-Eluting Coronary Stent Implantation.
Circ J
; 84(9): 1483-1492, 2020 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32684537
3.
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.
JAMA
; 321(24): 2414-2427, 2019 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31237644
4.
Sex Differences in Long-Term Clinical Outcomes in Patients With Atrial Fibrillation Undergoing Coronary Stent Implantation.
Circ J
; 82(7): 1754-1762, 2018 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29593146
5.
Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With High Bleeding Risk: Insight From the STOPDAPT-2 Trial.
Circulation
; 140(23): 1957-1959, 2019 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31560216
6.
Biodegradable or durable polymer drug-eluting stents in patients with coronary artery disease: ten-year outcomes of the randomised NEXT Trial.
EuroIntervention
; 19(5): e402-e413, 2023 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37395475
7.
SYNTAX Score and 1-Year Outcomes in the OPTIVUS-Complex PCI Study Multivessel Cohort.
Am J Cardiol
; 205: 431-441, 2023 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37660669
8.
Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients Who Underwent Complex Percutaneous Coronary Intervention: Insight From the STOPDAPT-2 Trial.
Circ Cardiovasc Interv
; 14(5): e010384, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34003662
9.
Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trial.
Cardiovasc Interv Ther
; 36(1): 91-103, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32086787
10.
One-year clinical outcomes of patients with versus without acute coronary syndrome with 3-month duration of dual antiplatelet therapy after everolimus-eluting stent implantation.
PLoS One
; 15(3): e0227612, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32210433
11.
Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years.
JACC Cardiovasc Interv
; 13(1): 116-127, 2020 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31918929
12.
Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke.
J Am Heart Assoc
; 8(22): e013356, 2019 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31701821
13.
Erratum to 'SYNTAX Score and 1-Year Outcomes in the OPTIVUS-Complex PCI Study Multivessel Cohort' [American Journal of Cardiology (2023) 431-441].
Am J Cardiol
; 211: 382, 2024 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38114058
14.
Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO-Kyoto Thrombotic and Bleeding Risk Scores.
J Am Heart Assoc
; 7(11)2018 05 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29789335
15.
CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in 2018.
Cardiovasc Interv Ther
; 33(2): 178-203, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29594964
16.
Five-year outcome of a randomised trial comparing second-generation drug-eluting stents using either biodegradable polymer or durable polymer: the NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent trial (NEXT).
EuroIntervention
; 14(7): 815-818, 2018 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29437036